Drug regulator suspends pharma firm from manufacturing eye drops

INDIA's drug regulator has suspended manufacturing and marketing permission of Mumbai-based ETOD Pharmaceuticals, which had claimed that their new eye drop could help people reduce dependency on reading glasses for those suffering from presbyopia, an age-related vision condition.

- KAVITA BAJELI-DATT

The Central Drugs Standard Control Organisation (CDSCO) had earlier granted the pharma company approval to manufacture and market their eye drop, Pres Vu, which the company said offers an advanced alternative that augments near vision within 15 minutes.

Taking serious note of the unauthorised promotion of the product, the CDSCO said that their permission to manufacture and market has been suspended till further notice.

This daily was the first to report that the Drug Controller General of India (DCGI), Dr Rajeev Singh Raghuvanshi, had sought an explanation from the company for its claims that raised doubts.